Edition:
United States

Synergy Pharmaceuticals Inc (SGYP.OQ)

SGYP.OQ on NASDAQ Stock Exchange Global Select Market

1.75USD
4:00pm EDT
Change (% chg)

$-0.02 (-1.13%)
Prev Close
$1.77
Open
$1.77
Day's High
$1.78
Day's Low
$1.73
Volume
459,542
Avg. Vol
712,969
52-wk High
$3.57
52-wk Low
$1.42

Chart for

About

Synergy Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The Company's product candidates include TRULANCE (plecanatide) and dolcanatide. The Company is engaged in the discovery, research and development efforts around analogs of uroguanylin... (more)

Overall

Beta: 1.16
Market Cap(Mil.): $434.26
Shares Outstanding(Mil.): 246.74
Dividend: --
Yield (%): --

Financials

  SGYP.OQ Industry Sector
P/E (TTM): -- 97.68 30.58
EPS (TTM): -0.64 -- --
ROI: -245.92 3.30 12.84
ROE: -- 2.30 15.02

BRIEF-Synergy Pharmaceuticals Reports Q1 Loss Per Share $0.15

* SYNERGY PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND BUSINESS UPDATE

May 10 2018

BRIEF-Synergy Pharmaceuticals Qtrly Loss Per Share ‍$0.16

* SYNERGY PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND BUSINESS UPDATE

Mar 01 2018

BRIEF-Cipher Pharmaceuticals Acquires Exclusive Canadian Rights To FDA-Approved Trulance® From Synergy Pharma

* CIPHER PHARMACEUTICALS ACQUIRES EXCLUSIVE CANADIAN RIGHTS TO FDA-APPROVED TRULANCE® FROM SYNERGY PHARMACEUTICALS

Feb 28 2018

Earnings vs. Estimates